nodes	percent_of_prediction	percent_of_DWPC	metapath
Leucovorin—Methotrexate—multiple sclerosis	0.489	1	CrCtD
Leucovorin—Pemetrexed—Methotrexate—multiple sclerosis	0.0647	0.2	CrCrCtD
Leucovorin—Raltitrexed—Methotrexate—multiple sclerosis	0.0647	0.2	CrCrCtD
Leucovorin—Pralatrexate—Methotrexate—multiple sclerosis	0.0647	0.2	CrCrCtD
Leucovorin—Folic Acid—Methotrexate—multiple sclerosis	0.0647	0.2	CrCrCtD
Leucovorin—Tetrahydrofolic acid—Methotrexate—multiple sclerosis	0.0647	0.2	CrCrCtD
Leucovorin—TYMS—Methotrexate—multiple sclerosis	0.0592	0.409	CbGbCtD
Leucovorin—ABCC3—Methotrexate—multiple sclerosis	0.0307	0.212	CbGbCtD
Leucovorin—ABCC4—Methotrexate—multiple sclerosis	0.0234	0.162	CbGbCtD
Leucovorin—ABCC2—Dexamethasone—multiple sclerosis	0.0173	0.12	CbGbCtD
Leucovorin—ABCC2—Methotrexate—multiple sclerosis	0.0139	0.0964	CbGbCtD
Leucovorin—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000301	0.0595	CbGpPWpGaD
Leucovorin—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000301	0.0595	CbGpPWpGaD
Leucovorin—TYMS—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000282	0.0557	CbGpPWpGaD
Leucovorin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000238	0.0471	CbGpPWpGaD
Leucovorin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000238	0.0471	CbGpPWpGaD
Leucovorin—ABCC3—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000233	0.0461	CbGpPWpGaD
Leucovorin—ABCC4—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000219	0.0434	CbGpPWpGaD
Leucovorin—ABCC2—Irinotecan Pathway—BCHE—multiple sclerosis	0.000211	0.0417	CbGpPWpGaD
Leucovorin—ABCC3—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000171	0.0339	CbGpPWpGaD
Leucovorin—ABCC4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000161	0.0318	CbGpPWpGaD
Leucovorin—ABCC4—Ectoderm Differentiation—AHI1—multiple sclerosis	0.00016	0.0317	CbGpPWpGaD
Leucovorin—TYMS—E2F transcription factor network—RRM1—multiple sclerosis	0.000149	0.0295	CbGpPWpGaD
Leucovorin—TYMS—Nucleotide metabolism—RRM1—multiple sclerosis	0.000142	0.028	CbGpPWpGaD
Leucovorin—ABCC2—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000136	0.0269	CbGpPWpGaD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	0.00013	0.0257	CbGpPWpGaD
Leucovorin—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.000123	0.00342	CcSEcCtD
Leucovorin—Hypersensitivity—Cladribine—multiple sclerosis	0.000121	0.00337	CcSEcCtD
Leucovorin—Malaise—Mitoxantrone—multiple sclerosis	0.000119	0.00332	CcSEcCtD
Leucovorin—Renal failure acute—Methotrexate—multiple sclerosis	0.000118	0.0033	CcSEcCtD
Leucovorin—Leukopenia—Mitoxantrone—multiple sclerosis	0.000118	0.0033	CcSEcCtD
Leucovorin—Asthenia—Cladribine—multiple sclerosis	0.000118	0.00328	CcSEcCtD
Leucovorin—ABCC4—Platelet degranulation—PLEK—multiple sclerosis	0.000116	0.023	CbGpPWpGaD
Leucovorin—Pruritus—Cladribine—multiple sclerosis	0.000116	0.00323	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000115	0.00321	CcSEcCtD
Leucovorin—Convulsion—Mitoxantrone—multiple sclerosis	0.000114	0.00319	CcSEcCtD
Leucovorin—Neuropathy peripheral—Betamethasone—multiple sclerosis	0.000113	0.00316	CcSEcCtD
Leucovorin—Neuropathy peripheral—Dexamethasone—multiple sclerosis	0.000113	0.00316	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.000113	0.00315	CcSEcCtD
Leucovorin—ABCC3—Recycling of bile acids and salts—ALB—multiple sclerosis	0.000113	0.0223	CbGpPWpGaD
Leucovorin—Diarrhoea—Cladribine—multiple sclerosis	0.000112	0.00313	CcSEcCtD
Leucovorin—Lethargy—Methotrexate—multiple sclerosis	0.000111	0.00311	CcSEcCtD
Leucovorin—Discomfort—Mitoxantrone—multiple sclerosis	0.000111	0.0031	CcSEcCtD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—PLEK—multiple sclerosis	0.000111	0.0219	CbGpPWpGaD
Leucovorin—Feeling abnormal—Azathioprine—multiple sclerosis	0.00011	0.00306	CcSEcCtD
Leucovorin—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000109	0.00304	CcSEcCtD
Leucovorin—Confusional state—Mitoxantrone—multiple sclerosis	0.000109	0.00303	CcSEcCtD
Leucovorin—Dizziness—Cladribine—multiple sclerosis	0.000108	0.00302	CcSEcCtD
Leucovorin—Erythema—Prednisolone—multiple sclerosis	0.000108	0.00302	CcSEcCtD
Leucovorin—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000108	0.00301	CcSEcCtD
Leucovorin—Infection—Mitoxantrone—multiple sclerosis	0.000107	0.00299	CcSEcCtD
Leucovorin—Shock—Mitoxantrone—multiple sclerosis	0.000106	0.00296	CcSEcCtD
Leucovorin—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000106	0.00294	CcSEcCtD
Leucovorin—Abdominal pain—Azathioprine—multiple sclerosis	0.000105	0.00294	CcSEcCtD
Leucovorin—Body temperature increased—Azathioprine—multiple sclerosis	0.000105	0.00294	CcSEcCtD
Leucovorin—Skin disorder—Mitoxantrone—multiple sclerosis	0.000105	0.00292	CcSEcCtD
Leucovorin—Vomiting—Cladribine—multiple sclerosis	0.000104	0.00291	CcSEcCtD
Leucovorin—Rash—Cladribine—multiple sclerosis	0.000103	0.00288	CcSEcCtD
Leucovorin—Dermatitis—Cladribine—multiple sclerosis	0.000103	0.00288	CcSEcCtD
Leucovorin—Anorexia—Mitoxantrone—multiple sclerosis	0.000103	0.00286	CcSEcCtD
Leucovorin—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000101	0.0028	CcSEcCtD
Leucovorin—Erythema—Triamcinolone—multiple sclerosis	9.96e-05	0.00278	CcSEcCtD
Leucovorin—Erythema—Methylprednisolone—multiple sclerosis	9.94e-05	0.00277	CcSEcCtD
Leucovorin—Neuropathy peripheral—Prednisone—multiple sclerosis	9.88e-05	0.00275	CcSEcCtD
Leucovorin—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	9.84e-05	0.0195	CbGpPWpGaD
Leucovorin—Hypersensitivity—Azathioprine—multiple sclerosis	9.82e-05	0.00274	CcSEcCtD
Leucovorin—Malaise—Prednisolone—multiple sclerosis	9.77e-05	0.00272	CcSEcCtD
Leucovorin—Dysgeusia—Triamcinolone—multiple sclerosis	9.76e-05	0.00272	CcSEcCtD
Leucovorin—Nausea—Cladribine—multiple sclerosis	9.74e-05	0.00272	CcSEcCtD
Leucovorin—Syncope—Prednisolone—multiple sclerosis	9.72e-05	0.00271	CcSEcCtD
Leucovorin—Dyspnoea—Mitoxantrone—multiple sclerosis	9.61e-05	0.00268	CcSEcCtD
Leucovorin—Loss of consciousness—Prednisolone—multiple sclerosis	9.52e-05	0.00266	CcSEcCtD
Leucovorin—Dyspepsia—Mitoxantrone—multiple sclerosis	9.49e-05	0.00265	CcSEcCtD
Leucovorin—Convulsion—Prednisolone—multiple sclerosis	9.39e-05	0.00262	CcSEcCtD
Leucovorin—Decreased appetite—Mitoxantrone—multiple sclerosis	9.37e-05	0.00261	CcSEcCtD
Leucovorin—Fatigue—Mitoxantrone—multiple sclerosis	9.29e-05	0.00259	CcSEcCtD
Leucovorin—Ill-defined disorder—Triamcinolone—multiple sclerosis	9.24e-05	0.00258	CcSEcCtD
Leucovorin—Ill-defined disorder—Methylprednisolone—multiple sclerosis	9.22e-05	0.00257	CcSEcCtD
Leucovorin—Constipation—Mitoxantrone—multiple sclerosis	9.22e-05	0.00257	CcSEcCtD
Leucovorin—Alopecia—Dexamethasone—multiple sclerosis	9.18e-05	0.00256	CcSEcCtD
Leucovorin—Alopecia—Betamethasone—multiple sclerosis	9.18e-05	0.00256	CcSEcCtD
Leucovorin—Diarrhoea—Azathioprine—multiple sclerosis	9.12e-05	0.00254	CcSEcCtD
Leucovorin—Discomfort—Prednisolone—multiple sclerosis	9.11e-05	0.00254	CcSEcCtD
Leucovorin—Erythema—Betamethasone—multiple sclerosis	9.04e-05	0.00252	CcSEcCtD
Leucovorin—Erythema—Dexamethasone—multiple sclerosis	9.04e-05	0.00252	CcSEcCtD
Leucovorin—Malaise—Triamcinolone—multiple sclerosis	8.99e-05	0.00251	CcSEcCtD
Leucovorin—Malaise—Methylprednisolone—multiple sclerosis	8.97e-05	0.0025	CcSEcCtD
Leucovorin—Syncope—Triamcinolone—multiple sclerosis	8.94e-05	0.00249	CcSEcCtD
Leucovorin—Syncope—Methylprednisolone—multiple sclerosis	8.92e-05	0.00249	CcSEcCtD
Leucovorin—Feeling abnormal—Mitoxantrone—multiple sclerosis	8.88e-05	0.00248	CcSEcCtD
Leucovorin—Anaphylactic shock—Prednisolone—multiple sclerosis	8.84e-05	0.00247	CcSEcCtD
Leucovorin—Dizziness—Azathioprine—multiple sclerosis	8.82e-05	0.00246	CcSEcCtD
Leucovorin—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	8.81e-05	0.00246	CcSEcCtD
Leucovorin—Loss of consciousness—Triamcinolone—multiple sclerosis	8.76e-05	0.00244	CcSEcCtD
Leucovorin—Loss of consciousness—Methylprednisolone—multiple sclerosis	8.74e-05	0.00244	CcSEcCtD
Leucovorin—Shock—Prednisolone—multiple sclerosis	8.7e-05	0.00243	CcSEcCtD
Leucovorin—Convulsion—Triamcinolone—multiple sclerosis	8.63e-05	0.00241	CcSEcCtD
Leucovorin—Convulsion—Methylprednisolone—multiple sclerosis	8.61e-05	0.0024	CcSEcCtD
Leucovorin—Urticaria—Mitoxantrone—multiple sclerosis	8.56e-05	0.00239	CcSEcCtD
Leucovorin—TYMS—Azacitidine—Cladribine—multiple sclerosis	8.54e-05	0.0491	CbGdCrCtD
Leucovorin—Body temperature increased—Mitoxantrone—multiple sclerosis	8.52e-05	0.00238	CcSEcCtD
Leucovorin—Abdominal pain—Mitoxantrone—multiple sclerosis	8.52e-05	0.00238	CcSEcCtD
Leucovorin—Vomiting—Azathioprine—multiple sclerosis	8.48e-05	0.00236	CcSEcCtD
Leucovorin—Rash—Azathioprine—multiple sclerosis	8.41e-05	0.00234	CcSEcCtD
Leucovorin—Dermatitis—Azathioprine—multiple sclerosis	8.4e-05	0.00234	CcSEcCtD
Leucovorin—Ill-defined disorder—Betamethasone—multiple sclerosis	8.39e-05	0.00234	CcSEcCtD
Leucovorin—Ill-defined disorder—Dexamethasone—multiple sclerosis	8.39e-05	0.00234	CcSEcCtD
Leucovorin—Discomfort—Triamcinolone—multiple sclerosis	8.38e-05	0.00234	CcSEcCtD
Leucovorin—Discomfort—Methylprednisolone—multiple sclerosis	8.36e-05	0.00233	CcSEcCtD
Leucovorin—Stomatitis—Methotrexate—multiple sclerosis	8.21e-05	0.00229	CcSEcCtD
Leucovorin—Confusional state—Methylprednisolone—multiple sclerosis	8.18e-05	0.00228	CcSEcCtD
Leucovorin—Malaise—Dexamethasone—multiple sclerosis	8.15e-05	0.00227	CcSEcCtD
Leucovorin—Malaise—Betamethasone—multiple sclerosis	8.15e-05	0.00227	CcSEcCtD
Leucovorin—Anaphylactic shock—Triamcinolone—multiple sclerosis	8.13e-05	0.00227	CcSEcCtD
Leucovorin—Anaphylactic shock—Methylprednisolone—multiple sclerosis	8.11e-05	0.00226	CcSEcCtD
Leucovorin—Syncope—Dexamethasone—multiple sclerosis	8.11e-05	0.00226	CcSEcCtD
Leucovorin—Syncope—Betamethasone—multiple sclerosis	8.11e-05	0.00226	CcSEcCtD
Leucovorin—Infection—Triamcinolone—multiple sclerosis	8.08e-05	0.00225	CcSEcCtD
Leucovorin—Infection—Methylprednisolone—multiple sclerosis	8.06e-05	0.00225	CcSEcCtD
Leucovorin—Shock—Triamcinolone—multiple sclerosis	8e-05	0.00223	CcSEcCtD
Leucovorin—Alopecia—Prednisone—multiple sclerosis	7.99e-05	0.00223	CcSEcCtD
Leucovorin—Shock—Methylprednisolone—multiple sclerosis	7.98e-05	0.00223	CcSEcCtD
Leucovorin—Loss of consciousness—Betamethasone—multiple sclerosis	7.95e-05	0.00222	CcSEcCtD
Leucovorin—Loss of consciousness—Dexamethasone—multiple sclerosis	7.95e-05	0.00222	CcSEcCtD
Leucovorin—Hypersensitivity—Mitoxantrone—multiple sclerosis	7.94e-05	0.00221	CcSEcCtD
Leucovorin—Nausea—Azathioprine—multiple sclerosis	7.92e-05	0.00221	CcSEcCtD
Leucovorin—Skin disorder—Methylprednisolone—multiple sclerosis	7.88e-05	0.0022	CcSEcCtD
Leucovorin—Erythema—Prednisone—multiple sclerosis	7.87e-05	0.0022	CcSEcCtD
Leucovorin—Convulsion—Betamethasone—multiple sclerosis	7.83e-05	0.00218	CcSEcCtD
Leucovorin—Convulsion—Dexamethasone—multiple sclerosis	7.83e-05	0.00218	CcSEcCtD
Leucovorin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	7.8e-05	0.0154	CbGpPWpGaD
Leucovorin—Asthenia—Mitoxantrone—multiple sclerosis	7.73e-05	0.00216	CcSEcCtD
Leucovorin—Discomfort—Betamethasone—multiple sclerosis	7.6e-05	0.00212	CcSEcCtD
Leucovorin—Discomfort—Dexamethasone—multiple sclerosis	7.6e-05	0.00212	CcSEcCtD
Leucovorin—Anaphylactic shock—Betamethasone—multiple sclerosis	7.38e-05	0.00206	CcSEcCtD
Leucovorin—Anaphylactic shock—Dexamethasone—multiple sclerosis	7.38e-05	0.00206	CcSEcCtD
Leucovorin—Diarrhoea—Mitoxantrone—multiple sclerosis	7.37e-05	0.00206	CcSEcCtD
Leucovorin—Infection—Betamethasone—multiple sclerosis	7.33e-05	0.00204	CcSEcCtD
Leucovorin—Infection—Dexamethasone—multiple sclerosis	7.33e-05	0.00204	CcSEcCtD
Leucovorin—Ill-defined disorder—Prednisone—multiple sclerosis	7.31e-05	0.00204	CcSEcCtD
Leucovorin—Feeling abnormal—Prednisolone—multiple sclerosis	7.29e-05	0.00203	CcSEcCtD
Leucovorin—Shock—Betamethasone—multiple sclerosis	7.26e-05	0.00202	CcSEcCtD
Leucovorin—Shock—Dexamethasone—multiple sclerosis	7.26e-05	0.00202	CcSEcCtD
Leucovorin—Dyspnoea—Triamcinolone—multiple sclerosis	7.25e-05	0.00202	CcSEcCtD
Leucovorin—Thrombocytopenia—Betamethasone—multiple sclerosis	7.22e-05	0.00201	CcSEcCtD
Leucovorin—Thrombocytopenia—Dexamethasone—multiple sclerosis	7.22e-05	0.00201	CcSEcCtD
Leucovorin—Dyspepsia—Triamcinolone—multiple sclerosis	7.16e-05	0.002	CcSEcCtD
Leucovorin—Dyspepsia—Methylprednisolone—multiple sclerosis	7.14e-05	0.00199	CcSEcCtD
Leucovorin—Malaise—Prednisone—multiple sclerosis	7.1e-05	0.00198	CcSEcCtD
Leucovorin—Syncope—Prednisone—multiple sclerosis	7.06e-05	0.00197	CcSEcCtD
Leucovorin—Anorexia—Dexamethasone—multiple sclerosis	7.03e-05	0.00196	CcSEcCtD
Leucovorin—Anorexia—Betamethasone—multiple sclerosis	7.03e-05	0.00196	CcSEcCtD
Leucovorin—Urticaria—Prednisolone—multiple sclerosis	7.02e-05	0.00196	CcSEcCtD
Leucovorin—Fatigue—Triamcinolone—multiple sclerosis	7.01e-05	0.00195	CcSEcCtD
Leucovorin—Fatigue—Methylprednisolone—multiple sclerosis	7e-05	0.00195	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	6.92e-05	0.0137	CbGpPWpGaD
Leucovorin—Loss of consciousness—Prednisone—multiple sclerosis	6.92e-05	0.00193	CcSEcCtD
Leucovorin—Vomiting—Mitoxantrone—multiple sclerosis	6.85e-05	0.00191	CcSEcCtD
Leucovorin—Convulsion—Prednisone—multiple sclerosis	6.82e-05	0.0019	CcSEcCtD
Leucovorin—Rash—Mitoxantrone—multiple sclerosis	6.8e-05	0.0019	CcSEcCtD
Leucovorin—Dermatitis—Mitoxantrone—multiple sclerosis	6.79e-05	0.00189	CcSEcCtD
Leucovorin—Chills—Methotrexate—multiple sclerosis	6.78e-05	0.00189	CcSEcCtD
Leucovorin—Feeling abnormal—Triamcinolone—multiple sclerosis	6.7e-05	0.00187	CcSEcCtD
Leucovorin—Feeling abnormal—Methylprednisolone—multiple sclerosis	6.69e-05	0.00186	CcSEcCtD
Leucovorin—Alopecia—Methotrexate—multiple sclerosis	6.68e-05	0.00186	CcSEcCtD
Leucovorin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	6.63e-05	0.00185	CcSEcCtD
Leucovorin—Discomfort—Prednisone—multiple sclerosis	6.62e-05	0.00185	CcSEcCtD
Leucovorin—Erythema—Methotrexate—multiple sclerosis	6.58e-05	0.00183	CcSEcCtD
Leucovorin—Hypersensitivity—Prednisolone—multiple sclerosis	6.52e-05	0.00182	CcSEcCtD
Leucovorin—Dyspepsia—Betamethasone—multiple sclerosis	6.5e-05	0.00181	CcSEcCtD
Leucovorin—Dyspepsia—Dexamethasone—multiple sclerosis	6.5e-05	0.00181	CcSEcCtD
Leucovorin—Urticaria—Triamcinolone—multiple sclerosis	6.46e-05	0.0018	CcSEcCtD
Leucovorin—Urticaria—Methylprednisolone—multiple sclerosis	6.45e-05	0.0018	CcSEcCtD
Leucovorin—Dysgeusia—Methotrexate—multiple sclerosis	6.44e-05	0.0018	CcSEcCtD
Leucovorin—Body temperature increased—Triamcinolone—multiple sclerosis	6.43e-05	0.00179	CcSEcCtD
Leucovorin—Anaphylactic shock—Prednisone—multiple sclerosis	6.43e-05	0.00179	CcSEcCtD
Leucovorin—Abdominal pain—Methylprednisolone—multiple sclerosis	6.41e-05	0.00179	CcSEcCtD
Leucovorin—Decreased appetite—Dexamethasone—multiple sclerosis	6.41e-05	0.00179	CcSEcCtD
Leucovorin—Decreased appetite—Betamethasone—multiple sclerosis	6.41e-05	0.00179	CcSEcCtD
Leucovorin—Nausea—Mitoxantrone—multiple sclerosis	6.4e-05	0.00179	CcSEcCtD
Leucovorin—Infection—Prednisone—multiple sclerosis	6.38e-05	0.00178	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	6.37e-05	0.00178	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Betamethasone—multiple sclerosis	6.37e-05	0.00178	CcSEcCtD
Leucovorin—Fatigue—Dexamethasone—multiple sclerosis	6.36e-05	0.00177	CcSEcCtD
Leucovorin—Fatigue—Betamethasone—multiple sclerosis	6.36e-05	0.00177	CcSEcCtD
Leucovorin—Shock—Prednisone—multiple sclerosis	6.32e-05	0.00176	CcSEcCtD
Leucovorin—Skin disorder—Prednisone—multiple sclerosis	6.24e-05	0.00174	CcSEcCtD
Leucovorin—Anorexia—Prednisone—multiple sclerosis	6.13e-05	0.00171	CcSEcCtD
Leucovorin—Ill-defined disorder—Methotrexate—multiple sclerosis	6.11e-05	0.0017	CcSEcCtD
Leucovorin—Feeling abnormal—Betamethasone—multiple sclerosis	6.08e-05	0.0017	CcSEcCtD
Leucovorin—Feeling abnormal—Dexamethasone—multiple sclerosis	6.08e-05	0.0017	CcSEcCtD
Leucovorin—Gastrointestinal pain—Betamethasone—multiple sclerosis	6.03e-05	0.00168	CcSEcCtD
Leucovorin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	6.03e-05	0.00168	CcSEcCtD
Leucovorin—Hypersensitivity—Triamcinolone—multiple sclerosis	5.99e-05	0.00167	CcSEcCtD
Leucovorin—Hypersensitivity—Methylprednisolone—multiple sclerosis	5.98e-05	0.00167	CcSEcCtD
Leucovorin—Malaise—Methotrexate—multiple sclerosis	5.93e-05	0.00165	CcSEcCtD
Leucovorin—ABCC3—Bile acid and bile salt metabolism—ALB—multiple sclerosis	5.89e-05	0.0116	CbGpPWpGaD
Leucovorin—Leukopenia—Methotrexate—multiple sclerosis	5.89e-05	0.00164	CcSEcCtD
Leucovorin—Urticaria—Dexamethasone—multiple sclerosis	5.86e-05	0.00163	CcSEcCtD
Leucovorin—Urticaria—Betamethasone—multiple sclerosis	5.86e-05	0.00163	CcSEcCtD
Leucovorin—Dizziness—Prednisolone—multiple sclerosis	5.85e-05	0.00163	CcSEcCtD
Leucovorin—Asthenia—Triamcinolone—multiple sclerosis	5.83e-05	0.00163	CcSEcCtD
Leucovorin—Body temperature increased—Dexamethasone—multiple sclerosis	5.83e-05	0.00163	CcSEcCtD
Leucovorin—Abdominal pain—Dexamethasone—multiple sclerosis	5.83e-05	0.00163	CcSEcCtD
Leucovorin—Abdominal pain—Betamethasone—multiple sclerosis	5.83e-05	0.00163	CcSEcCtD
Leucovorin—Body temperature increased—Betamethasone—multiple sclerosis	5.83e-05	0.00163	CcSEcCtD
Leucovorin—Asthenia—Methylprednisolone—multiple sclerosis	5.82e-05	0.00162	CcSEcCtD
Leucovorin—Pruritus—Triamcinolone—multiple sclerosis	5.75e-05	0.0016	CcSEcCtD
Leucovorin—Pruritus—Methylprednisolone—multiple sclerosis	5.74e-05	0.0016	CcSEcCtD
Leucovorin—Convulsion—Methotrexate—multiple sclerosis	5.7e-05	0.00159	CcSEcCtD
Leucovorin—Dyspepsia—Prednisone—multiple sclerosis	5.66e-05	0.00158	CcSEcCtD
Leucovorin—Decreased appetite—Prednisone—multiple sclerosis	5.59e-05	0.00156	CcSEcCtD
Leucovorin—Rash—Prednisolone—multiple sclerosis	5.58e-05	0.00155	CcSEcCtD
Leucovorin—Dermatitis—Prednisolone—multiple sclerosis	5.57e-05	0.00155	CcSEcCtD
Leucovorin—Diarrhoea—Methylprednisolone—multiple sclerosis	5.55e-05	0.00155	CcSEcCtD
Leucovorin—Fatigue—Prednisone—multiple sclerosis	5.54e-05	0.00154	CcSEcCtD
Leucovorin—Discomfort—Methotrexate—multiple sclerosis	5.53e-05	0.00154	CcSEcCtD
Leucovorin—Constipation—Prednisone—multiple sclerosis	5.49e-05	0.00153	CcSEcCtD
Leucovorin—TYMS—Clobetasol propionate—Methylprednisolone—multiple sclerosis	5.48e-05	0.0315	CbGdCrCtD
Leucovorin—Confusional state—Methotrexate—multiple sclerosis	5.41e-05	0.00151	CcSEcCtD
Leucovorin—TYMS—Flunisolide—Methylprednisolone—multiple sclerosis	5.41e-05	0.0311	CbGdCrCtD
Leucovorin—TYMS—Clobetasol propionate—Betamethasone—multiple sclerosis	5.4e-05	0.031	CbGdCrCtD
Leucovorin—TYMS—Clobetasol propionate—Dexamethasone—multiple sclerosis	5.4e-05	0.031	CbGdCrCtD
Leucovorin—Dizziness—Triamcinolone—multiple sclerosis	5.38e-05	0.0015	CcSEcCtD
Leucovorin—Anaphylactic shock—Methotrexate—multiple sclerosis	5.37e-05	0.0015	CcSEcCtD
Leucovorin—Dizziness—Methylprednisolone—multiple sclerosis	5.37e-05	0.0015	CcSEcCtD
Leucovorin—TYMS—Triamcinolone—Methylprednisolone—multiple sclerosis	5.36e-05	0.0308	CbGdCrCtD
Leucovorin—Infection—Methotrexate—multiple sclerosis	5.34e-05	0.00149	CcSEcCtD
Leucovorin—TYMS—Flunisolide—Dexamethasone—multiple sclerosis	5.33e-05	0.0306	CbGdCrCtD
Leucovorin—TYMS—Flunisolide—Betamethasone—multiple sclerosis	5.33e-05	0.0306	CbGdCrCtD
Leucovorin—Feeling abnormal—Prednisone—multiple sclerosis	5.3e-05	0.00148	CcSEcCtD
Leucovorin—Asthenia—Dexamethasone—multiple sclerosis	5.29e-05	0.00148	CcSEcCtD
Leucovorin—Asthenia—Betamethasone—multiple sclerosis	5.29e-05	0.00148	CcSEcCtD
Leucovorin—TYMS—Clobetasol propionate—Triamcinolone—multiple sclerosis	5.27e-05	0.0303	CbGdCrCtD
Leucovorin—TYMS—Triamcinolone—Betamethasone—multiple sclerosis	5.27e-05	0.0303	CbGdCrCtD
Leucovorin—TYMS—Triamcinolone—Dexamethasone—multiple sclerosis	5.27e-05	0.0303	CbGdCrCtD
Leucovorin—Thrombocytopenia—Methotrexate—multiple sclerosis	5.26e-05	0.00147	CcSEcCtD
Leucovorin—Gastrointestinal pain—Prednisone—multiple sclerosis	5.25e-05	0.00147	CcSEcCtD
Leucovorin—Nausea—Prednisolone—multiple sclerosis	5.25e-05	0.00146	CcSEcCtD
Leucovorin—TYMS—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	5.23e-05	0.03	CbGdCrCtD
Leucovorin—Pruritus—Dexamethasone—multiple sclerosis	5.22e-05	0.00146	CcSEcCtD
Leucovorin—Pruritus—Betamethasone—multiple sclerosis	5.22e-05	0.00146	CcSEcCtD
Leucovorin—Skin disorder—Methotrexate—multiple sclerosis	5.22e-05	0.00145	CcSEcCtD
Leucovorin—TYMS—Flunisolide—Triamcinolone—multiple sclerosis	5.21e-05	0.0299	CbGdCrCtD
Leucovorin—Vomiting—Triamcinolone—multiple sclerosis	5.17e-05	0.00144	CcSEcCtD
Leucovorin—Vomiting—Methylprednisolone—multiple sclerosis	5.16e-05	0.00144	CcSEcCtD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	5.16e-05	0.0102	CbGpPWpGaD
Leucovorin—TYMS—Fluticasone Propionate—Betamethasone—multiple sclerosis	5.14e-05	0.0295	CbGdCrCtD
Leucovorin—TYMS—Fluticasone Propionate—Dexamethasone—multiple sclerosis	5.14e-05	0.0295	CbGdCrCtD
Leucovorin—Rash—Triamcinolone—multiple sclerosis	5.13e-05	0.00143	CcSEcCtD
Leucovorin—Dermatitis—Triamcinolone—multiple sclerosis	5.12e-05	0.00143	CcSEcCtD
Leucovorin—Anorexia—Methotrexate—multiple sclerosis	5.12e-05	0.00143	CcSEcCtD
Leucovorin—Rash—Methylprednisolone—multiple sclerosis	5.12e-05	0.00143	CcSEcCtD
Leucovorin—Dermatitis—Methylprednisolone—multiple sclerosis	5.11e-05	0.00143	CcSEcCtD
Leucovorin—Urticaria—Prednisone—multiple sclerosis	5.1e-05	0.00142	CcSEcCtD
Leucovorin—Body temperature increased—Prednisone—multiple sclerosis	5.08e-05	0.00142	CcSEcCtD
Leucovorin—Abdominal pain—Prednisone—multiple sclerosis	5.08e-05	0.00142	CcSEcCtD
Leucovorin—Diarrhoea—Dexamethasone—multiple sclerosis	5.05e-05	0.00141	CcSEcCtD
Leucovorin—Diarrhoea—Betamethasone—multiple sclerosis	5.05e-05	0.00141	CcSEcCtD
Leucovorin—TYMS—Fluticasone Propionate—Triamcinolone—multiple sclerosis	5.02e-05	0.0289	CbGdCrCtD
Leucovorin—TYMS—Clobetasol propionate—Prednisone—multiple sclerosis	5.01e-05	0.0288	CbGdCrCtD
Leucovorin—TYMS—Flunisolide—Prednisone—multiple sclerosis	4.94e-05	0.0284	CbGdCrCtD
Leucovorin—TYMS—Diflorasone—Methylprednisolone—multiple sclerosis	4.94e-05	0.0284	CbGdCrCtD
Leucovorin—TYMS—Triamcinolone—Prednisone—multiple sclerosis	4.89e-05	0.0281	CbGdCrCtD
Leucovorin—TYMS—Clobetasol propionate—Prednisolone—multiple sclerosis	4.89e-05	0.0281	CbGdCrCtD
Leucovorin—Dizziness—Betamethasone—multiple sclerosis	4.88e-05	0.00136	CcSEcCtD
Leucovorin—Dizziness—Dexamethasone—multiple sclerosis	4.88e-05	0.00136	CcSEcCtD
Leucovorin—TYMS—Diflorasone—Betamethasone—multiple sclerosis	4.86e-05	0.0279	CbGdCrCtD
Leucovorin—TYMS—Diflorasone—Dexamethasone—multiple sclerosis	4.86e-05	0.0279	CbGdCrCtD
Leucovorin—Nausea—Triamcinolone—multiple sclerosis	4.83e-05	0.00135	CcSEcCtD
Leucovorin—TYMS—Flunisolide—Prednisolone—multiple sclerosis	4.82e-05	0.0277	CbGdCrCtD
Leucovorin—Nausea—Methylprednisolone—multiple sclerosis	4.82e-05	0.00134	CcSEcCtD
Leucovorin—Dyspnoea—Methotrexate—multiple sclerosis	4.79e-05	0.00134	CcSEcCtD
Leucovorin—TYMS—Triamcinolone—Prednisolone—multiple sclerosis	4.77e-05	0.0274	CbGdCrCtD
Leucovorin—TYMS—Diflorasone—Triamcinolone—multiple sclerosis	4.75e-05	0.0273	CbGdCrCtD
Leucovorin—Hypersensitivity—Prednisone—multiple sclerosis	4.73e-05	0.00132	CcSEcCtD
Leucovorin—Dyspepsia—Methotrexate—multiple sclerosis	4.73e-05	0.00132	CcSEcCtD
Leucovorin—Vomiting—Dexamethasone—multiple sclerosis	4.69e-05	0.00131	CcSEcCtD
Leucovorin—Vomiting—Betamethasone—multiple sclerosis	4.69e-05	0.00131	CcSEcCtD
Leucovorin—Decreased appetite—Methotrexate—multiple sclerosis	4.67e-05	0.0013	CcSEcCtD
Leucovorin—Rash—Betamethasone—multiple sclerosis	4.65e-05	0.0013	CcSEcCtD
Leucovorin—Rash—Dexamethasone—multiple sclerosis	4.65e-05	0.0013	CcSEcCtD
Leucovorin—Dermatitis—Betamethasone—multiple sclerosis	4.65e-05	0.0013	CcSEcCtD
Leucovorin—Dermatitis—Dexamethasone—multiple sclerosis	4.65e-05	0.0013	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Methotrexate—multiple sclerosis	4.64e-05	0.00129	CcSEcCtD
Leucovorin—Fatigue—Methotrexate—multiple sclerosis	4.63e-05	0.00129	CcSEcCtD
Leucovorin—Asthenia—Prednisone—multiple sclerosis	4.61e-05	0.00129	CcSEcCtD
Leucovorin—Pruritus—Prednisone—multiple sclerosis	4.55e-05	0.00127	CcSEcCtD
Leucovorin—TYMS—Diflorasone—Prednisone—multiple sclerosis	4.51e-05	0.0259	CbGdCrCtD
Leucovorin—Feeling abnormal—Methotrexate—multiple sclerosis	4.43e-05	0.00123	CcSEcCtD
Leucovorin—TYMS—Diflorasone—Prednisolone—multiple sclerosis	4.4e-05	0.0253	CbGdCrCtD
Leucovorin—Diarrhoea—Prednisone—multiple sclerosis	4.4e-05	0.00123	CcSEcCtD
Leucovorin—Gastrointestinal pain—Methotrexate—multiple sclerosis	4.39e-05	0.00122	CcSEcCtD
Leucovorin—Nausea—Dexamethasone—multiple sclerosis	4.38e-05	0.00122	CcSEcCtD
Leucovorin—Nausea—Betamethasone—multiple sclerosis	4.38e-05	0.00122	CcSEcCtD
Leucovorin—TYMS—Budesonide—Methylprednisolone—multiple sclerosis	4.33e-05	0.0249	CbGdCrCtD
Leucovorin—ABCC4—Hemostasis—CD58—multiple sclerosis	4.3e-05	0.0085	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—MERTK—multiple sclerosis	4.3e-05	0.0085	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—SELPLG—multiple sclerosis	4.3e-05	0.0085	CbGpPWpGaD
Leucovorin—Urticaria—Methotrexate—multiple sclerosis	4.27e-05	0.00119	CcSEcCtD
Leucovorin—TYMS—Budesonide—Betamethasone—multiple sclerosis	4.26e-05	0.0245	CbGdCrCtD
Leucovorin—TYMS—Budesonide—Dexamethasone—multiple sclerosis	4.26e-05	0.0245	CbGdCrCtD
Leucovorin—Dizziness—Prednisone—multiple sclerosis	4.25e-05	0.00118	CcSEcCtD
Leucovorin—Body temperature increased—Methotrexate—multiple sclerosis	4.25e-05	0.00118	CcSEcCtD
Leucovorin—Abdominal pain—Methotrexate—multiple sclerosis	4.25e-05	0.00118	CcSEcCtD
Leucovorin—TYMS—Budesonide—Triamcinolone—multiple sclerosis	4.16e-05	0.0239	CbGdCrCtD
Leucovorin—Vomiting—Prednisone—multiple sclerosis	4.09e-05	0.00114	CcSEcCtD
Leucovorin—Rash—Prednisone—multiple sclerosis	4.05e-05	0.00113	CcSEcCtD
Leucovorin—Dermatitis—Prednisone—multiple sclerosis	4.05e-05	0.00113	CcSEcCtD
Leucovorin—Hypersensitivity—Methotrexate—multiple sclerosis	3.96e-05	0.0011	CcSEcCtD
Leucovorin—TYMS—Budesonide—Prednisone—multiple sclerosis	3.95e-05	0.0227	CbGdCrCtD
Leucovorin—TYMS—Budesonide—Prednisolone—multiple sclerosis	3.86e-05	0.0222	CbGdCrCtD
Leucovorin—Asthenia—Methotrexate—multiple sclerosis	3.85e-05	0.00107	CcSEcCtD
Leucovorin—Nausea—Prednisone—multiple sclerosis	3.82e-05	0.00106	CcSEcCtD
Leucovorin—Pruritus—Methotrexate—multiple sclerosis	3.8e-05	0.00106	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	3.79e-05	0.0075	CbGpPWpGaD
Leucovorin—TYMS—Danazol—Prednisone—multiple sclerosis	3.79e-05	0.0218	CbGdCrCtD
Leucovorin—Diarrhoea—Methotrexate—multiple sclerosis	3.67e-05	0.00102	CcSEcCtD
Leucovorin—Dizziness—Methotrexate—multiple sclerosis	3.55e-05	0.00099	CcSEcCtD
Leucovorin—Vomiting—Methotrexate—multiple sclerosis	3.41e-05	0.000952	CcSEcCtD
Leucovorin—Rash—Methotrexate—multiple sclerosis	3.39e-05	0.000944	CcSEcCtD
Leucovorin—Dermatitis—Methotrexate—multiple sclerosis	3.38e-05	0.000943	CcSEcCtD
Leucovorin—ABCC3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.23e-05	0.00638	CbGpPWpGaD
Leucovorin—Nausea—Methotrexate—multiple sclerosis	3.19e-05	0.000889	CcSEcCtD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.16e-05	0.00624	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.16e-05	0.00624	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	3.04e-05	0.00602	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.04e-05	0.006	CbGpPWpGaD
Leucovorin—ABCC4—Platelet degranulation—ALB—multiple sclerosis	2.92e-05	0.00578	CbGpPWpGaD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—multiple sclerosis	2.79e-05	0.00551	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PLEK—multiple sclerosis	2.66e-05	0.00525	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.61e-05	0.00515	CbGpPWpGaD
Leucovorin—TYMS—E2F transcription factor network—MYC—multiple sclerosis	2.56e-05	0.00507	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.56e-05	0.00506	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—FAS—multiple sclerosis	2.5e-05	0.00495	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.45e-05	0.00484	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—SRM—multiple sclerosis	2.41e-05	0.00477	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.3e-05	0.00455	CbGpPWpGaD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	2.23e-05	0.0044	CbGpPWpGaD
Leucovorin—ABCC4—Ectoderm Differentiation—CCL2—multiple sclerosis	2.03e-05	0.00401	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—SRM—multiple sclerosis	2e-05	0.00394	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.94e-05	0.00384	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.93e-05	0.00382	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—SELE—multiple sclerosis	1.87e-05	0.0037	CbGpPWpGaD
Leucovorin—TYMS—G1/S Transition—MYC—multiple sclerosis	1.86e-05	0.00368	CbGpPWpGaD
Leucovorin—ABCC4—Platelet degranulation—TGFB1—multiple sclerosis	1.85e-05	0.00366	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.82e-05	0.0036	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	1.79e-05	0.00355	CbGpPWpGaD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	1.76e-05	0.00348	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.71e-05	0.00338	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CYP24A1—multiple sclerosis	1.7e-05	0.00336	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CYP27B1—multiple sclerosis	1.7e-05	0.00336	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.61e-05	0.00318	CbGpPWpGaD
Leucovorin—TYMS—Mitotic G1-G1/S phases—MYC—multiple sclerosis	1.57e-05	0.0031	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—GPC5—multiple sclerosis	1.55e-05	0.00307	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.53e-05	0.00303	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CYP27B1—multiple sclerosis	1.41e-05	0.00278	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CYP24A1—multiple sclerosis	1.41e-05	0.00278	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.37e-05	0.00272	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.36e-05	0.00268	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—ITGA4—multiple sclerosis	1.35e-05	0.00268	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—IFNB1—multiple sclerosis	1.34e-05	0.00266	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	1.3e-05	0.00256	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—RRM1—multiple sclerosis	1.29e-05	0.00254	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—GPC5—multiple sclerosis	1.29e-05	0.00254	CbGpPWpGaD
Leucovorin—ABCC3—NRF2 pathway—TGFB1—multiple sclerosis	1.22e-05	0.0024	CbGpPWpGaD
Leucovorin—ABCC4—Ectoderm Differentiation—MYC—multiple sclerosis	1.2e-05	0.00237	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.19e-05	0.00235	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.18e-05	0.00234	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.16e-05	0.0023	CbGpPWpGaD
Leucovorin—ABCC4—NRF2 pathway—TGFB1—multiple sclerosis	1.14e-05	0.00226	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.11e-05	0.00219	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—RRM1—multiple sclerosis	1.07e-05	0.00211	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	1.05e-05	0.00208	CbGpPWpGaD
Leucovorin—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	9.64e-06	0.00191	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—IL2RA—multiple sclerosis	9.25e-06	0.00183	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—IL6—multiple sclerosis	8.57e-06	0.00169	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.27e-06	0.00163	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	8.2e-06	0.00162	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	8.05e-06	0.00159	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—BCHE—multiple sclerosis	7.39e-06	0.00146	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.1e-06	0.0014	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—ALB—multiple sclerosis	6.69e-06	0.00132	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.47e-06	0.00128	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.16e-06	0.00122	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—BCHE—multiple sclerosis	6.12e-06	0.00121	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.79e-06	0.00114	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—MYC—multiple sclerosis	5.75e-06	0.00114	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	5.62e-06	0.00111	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—IL2—multiple sclerosis	5.42e-06	0.00107	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—MYC—multiple sclerosis	5.14e-06	0.00102	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—MAPK1—multiple sclerosis	5.03e-06	0.000994	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.88e-06	0.000965	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—APOE—multiple sclerosis	4.45e-06	0.000879	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—TGFB1—multiple sclerosis	4.23e-06	0.000836	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—MAPK1—multiple sclerosis	4.15e-06	0.00082	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—POMC—multiple sclerosis	3.82e-06	0.000755	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—APOE—multiple sclerosis	3.68e-06	0.000728	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ALB—multiple sclerosis	3.48e-06	0.000689	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—POMC—multiple sclerosis	3.16e-06	0.000625	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ALB—multiple sclerosis	2.88e-06	0.00057	CbGpPWpGaD
